⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tigulixostat SCHEMBL29767493 | 1.00 | — | — | |
| Tigulixostat SCHEMBL12987665 | 0.99 | — | — | |
| Tigulixostat SCHEMBL12987674 | 0.99 | — | — | |
| SCHEMBL27176717 | 0.95 | — | — | |
| SCHEMBL30733839 | 0.95 | — | — | |
| SCHEMBL26613989 | 0.92 | — | — | |
| SCHEMBL1647681 | 0.90 | — | — | |
| Tigulixostat SCHEMBL12987668 | 0.89 | — | — | |
| Tigulixostat SCHEMBL29082873 | 0.89 | — | — | |
| SCHEMBL1648962 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240415814-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | LG CHEMICAL LTD (KR) | 2024-12-19 | — | — | US | claimed |
| US-20240293369-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | LG CHEM, LTD. (KR) | 2024-09-05 | — | — | US | claimed |
| US-20240293331-A1 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | LG CHEM, LTD. (KR) | 2024-09-05 | — | — | US | claimed |
| US-20240285583-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | LG CHEM, LTD. (KR) | 2024-08-29 | — | — | US | claimed |
| US-20240216331-A1 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | LG CHEM, LTD. (KR) | 2024-07-04 | — | — | US | claimed |
| US-20240173259-A1 | ORAL FORMULATION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID AND METHOD FOR PREPARING SAME | LG CHEM, LTD. (KR) | 2024-05-30 | — | — | US | claimed |
| EP-4360631-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Lg Chem, Ltd. (KR) | 2024-05-01 | — | — | EP | claimed |
| EP-4344701-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Lg Chem, Ltd. (KR) | 2024-04-03 | — | — | EP | claimed |
| EP-4342458-A1 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Lg Chem, Ltd. (KR) | 2024-03-27 | — | — | EP | claimed |
| EP-4324459-A1 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Lg Chem, Ltd. (KR) | 2024-02-21 | — | — | EP | claimed |
| WO-2022265382-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | 주식회사 엘지화학 | 2022-12-22 | — | — | WO | claimed |
| WO-2022265442-A1 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | 주식회사 엘지화학 | 2022-12-22 | — | — | WO | claimed |
| WO-2022220636-A1 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | 주식회사 엘지화학 | 2022-10-20 | — | — | WO | claimed |
| WO-2022119270-A1 | ORAL FORMULATION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID AND METHOD FOR PREPARING SAME | 주식회사 엘지화학 | 2022-06-09 | — | — | WO | claimed |
| WO-2022119269-A1 | STABLE ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | 주식회사 엘지화학 | 2022-06-09 | — | — | WO | claimed |
| EP-2467378-B1 | COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD (KR) | 2016-07-27 | — | — | EP | claimed |
| US-8729273-B2 | Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same | LG LIFE SCIENCES LTD. (KR) | 2014-05-20 | — | — | US | claimed |
| US-20120184582-A1 | NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG CHEM, LTD. (KR) | 2012-07-19 | — | — | US | claimed |
| EP-2467378-A2 | NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG Life Sciences Ltd (KR) | 2012-06-27 | — | — | EP | claimed |
| WO-2011043568-A2 | NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2011-04-14 | — | — | WO | claimed |